NCBiotech News

Duke scientists say an instrumentation grant from NCBiotech enables them to use cutting-edge digital imaging and AI technologies to advance cancer research, diagnostics and to support a vast new initiative called AI Health.

T3D Therapeutics has enlisted an all-star team of Alzheimer’s disease experts to guide the science behind its potential drugs for treating the affliction.

T3D Therapeutics is launching a Phase 2 clinical trial with its unique product candidate, T3D-959, to treat mild to moderate forms of Alzheimer’s disease.

AskBio has launched a unique outreach program, called AskFirst, to communicate information and support during clinical trials to patients and their families.

Bioscience ventures in southeastern NC can compete for up to $20,000 in awards this spring through a new program created by NCBiotech and supported by UNCW and the New Hanover Regional Medical Center.

A successful Phase 3 trial of Polarean Imaging’s drug-device combination for lung imaging has the Research Triangle Park company poised to seek next-step advice from FDA regulators.

The North Carolina Biotechnology Center awarded 23 grants and loans totaling $2.1 million during the past fiscal quarter to bioscience companies, universities and non-profit organizations.

Altavant Sciences, headquartered in Cary, is balancing the development of two promising compounds to treat two rare respiratory diseases.

Raleigh-based biotechnology company Arrevus has received an important FDA designation to support development of its drug to address the worsening symptoms of cystic fibrosis.

Researchers at the University of North Carolina at Chapel Hill are one step closer to a possible new treatment against multiple myeloma, a devastating type of blood cancer.

Duke University has teamed up with Deerfield Management, a New York-based health care investment firm, to form a drug spinout company called Four Points Innovation.

bluebird bio, a gene therapy company with operations in Durham, has launched for the first time its treatment for a severe inherited blood disorder, in Germany.

Raleigh ranks second on Numbeo’s Quality of Life Index for 2020 and Charlotte is #9 out of the 227 cities ranked around the world.

Scientists say treating allergies in people provides insight into ways to treat animals with similar problems.

Plant Response, a Spanish agricultural biologicals company with North American headquarters in Durham, has acquired Pathway BioLogic of Plant City, Fla